Princeton Global Asset Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Princeton Global Asset Management’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.73K	Hold	150	–	–	﹤0.01%	650
2026 Q1	$5.15K	Buy	+150	New	+$5.13K	﹤0.01%	684

Other funds holding FTXH

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Princeton Global Asset Management's FTXH Position: Q2 2026 in Review

Princeton Global Asset Management held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q2 2026 at 150 shares worth $5.73K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Princeton Global Asset Management first reported a position in FTXH in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Princeton Global Asset Management held 150 shares of First Trust Nasdaq Pharmaceuticals ETF worth $5.73K as of Q2 2026.
Princeton Global Asset Management left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q2 2026.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #650 holding.
Princeton Global Asset Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
6 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.